| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |